Last reviewed · How we verify

NCT04369729

Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache

Completed Last updated 12 September 2025
What this trial tests

trial in Post-Traumatic Headache in 101 participants. Completed in 31 August 2025.

Timeline
9 September 2020
Primary endpoint
31 August 2025
31 August 2025

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment101
Start date9 September 2020
Primary completion31 August 2025
Estimated completion31 August 2025
Sites5 locations across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 70, any sex, with Post-Traumatic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post-Traumatic Headache

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04369729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing